Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery—Part I: Parenteral Applications

[1]  O. Casasnovas,et al.  Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[3]  Chung C. Hsu,et al.  Less-painful emulsion formulations for intravenous administration of clarithromycin , 1994 .

[4]  J. Schüttler,et al.  [Anesthesia induction using etomidate in a lipid emulsion]. , 1993, Der Anaesthesist.

[5]  Bradley D Anderson,et al.  Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. , 2004, Journal of pharmaceutical sciences.

[6]  J. Meunier,et al.  Dynamics of Spontaneous Emulsification for Fabrication of Oil in Water Emulsions , 2000 .

[7]  P. Gupta,et al.  Stability of a less-painful intravenous emulsion of clarithromycin , 1995 .

[8]  Floyd.  Top ten considerations in the development of parenteral emulsions. , 1999, Pharmaceutical science & technology today.

[9]  C. Price,et al.  Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. , 1998, Journal of pharmaceutical sciences.

[10]  Huiling Mu,et al.  The digestion of dietary triacylglycerols. , 2004, Progress in lipid research.

[11]  A. Tibell,et al.  Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution. , 1995, Pharmacology & toxicology.

[12]  S. S. Davis,et al.  Toxicity of Solubilized and Colloidal Amphotericin B Formulations to Human Erythrocytes , 1988, The Journal of pharmacy and pharmacology.

[13]  L. Benet,et al.  Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy , 1995, Molecular carcinogenesis.

[14]  S. Benita,et al.  Physostigmine emulsion: a new injectable controlled release delivery system , 1986 .

[15]  Denham S. Ward,et al.  Pharmacodynamics and Pharmacokinetics of Propofol in a Medium-Chain Triglyceride Emulsion , 2002, Anesthesiology.

[16]  Fritz Wittwer,et al.  Liquid Filled and Sealed Hard Gelatin Capsules , 1986 .

[17]  Y. Barenholz,et al.  Efficacy Evaluation of a Novel Submicron Miconazole Emulsion in a Murine Cryptococcosis Model , 1995, Pharmaceutical Research.

[18]  W. C. Griffin.  Classification of surface-active agents by "HLB" , 1946 .

[19]  Robert G Laughlin,et al.  The Aqueous Phase Behavior of Surfactants , 1994 .

[20]  S. Engstrom,et al.  Drug compatibility with the sponge phases formed in monoolein, water, and propylene glycol or poly(ethylene glycol). , 1998, Journal of pharmaceutical sciences.

[21]  D. Carney,et al.  Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. , 1993, AJR. American journal of roentgenology.

[22]  M. Lawrence,et al.  Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. , 1998, Journal of pharmaceutical sciences.

[23]  C. Shim,et al.  Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338 , 1995 .

[24]  C. Barbé,et al.  Oxidative stability of semi-solid excipient mixtures with corn oil and its implication in the degradation of vitamin A , 1997 .

[25]  P. Carl,et al.  Pregnanolone emulsion , 1987, Anaesthesia.

[26]  P. Constantinides,et al.  Tocol emulsions for drug solubilization and parenteral delivery. , 2004, Advanced drug delivery reviews.

[27]  S. S. Davis,et al.  Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip , 1993, Journal of clinical pharmacy and therapeutics.

[28]  T. Hellweg.  Phase structures of microemulsions , 2002 .

[29]  C. McCoy,et al.  An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[30]  C. Porter,et al.  Uptake of drugs into the intestinal lymphatics after oral administration , 1997 .

[31]  M. Groves,et al.  The Influence of Free Fatty Acid Formation on the pH of Phospholipid-Stabilized Triglyceride Emulsions , 1993, Pharmaceutical Research.

[32]  J. Patrick,et al.  Comparative bioavailability of a lipophilic steroid. , 1978, Journal of pharmaceutical sciences.

[33]  S. Fukushima,et al.  Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. , 2000, Advanced drug delivery reviews.

[34]  M. Hashida,et al.  Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion , 1987, Cancer.

[35]  N. Jamieson,et al.  Cyclosporin absorption from microemulsion formulation in liver transplant recipient , 1993, The Lancet.

[36]  W. M. Haynes.  CRC Handbook of Chemistry and Physics , 1990 .

[37]  O. Werner,et al.  Halothane Dissolved in Fat as an Intravenous Anaesthetic to Rats , 1984, Acta anaesthesiologica Scandinavica.

[38]  D. Thompson,et al.  Oral bioavailability of vancomycin solid-state emulsions , 1995 .

[39]  H. Ohshima,et al.  Physicochemical Characterization of Parenteral Lipid Emulsion: Determination of Hamaker Constants and Activation Energy of Coalescence , 1995, Pharmaceutical Research.

[40]  H. Kristensen,et al.  Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  K. Taeger,et al.  [Etomidate using a new solubilizer. Experimental clinical studies on venous tolerance and bioavailability]. , 1990, Der Anaesthesist.

[42]  D. Fleisher,et al.  Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.

[43]  A Müllertz,et al.  A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[44]  V. Stella,et al.  Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene , 1992 .

[45]  J. Dundee,et al.  BIOAVAILABILITY OF INTRAVENOUS DIAZEPAM , 1984, The Lancet.

[46]  G. Wolf,et al.  Preclinical and clinical studies on lymph node imaging using perflubron emulsion. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[47]  R. Jandacek,et al.  The rapid hydrolysis and efficient absorption of triglycerides with octanoic acid in the 1 and 3 positions and long-chain fatty acid in the 2 position. , 1987, The American journal of clinical nutrition.

[48]  A. Kurihara,et al.  Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats. , 1996, Biological & pharmaceutical bulletin.

[49]  L. C. Collins-Gold,et al.  Parenteral emulsions for drug delivery , 1990 .

[50]  C. Pouton,et al.  Structure and function of gastro-intestinal lipases , 1997 .

[51]  J. A. V. BUTLER,et al.  Theory of the Stability of Lyophobic Colloids , 1948, Nature.

[52]  Ping Gao,et al.  Application of a Mixture Experimental Design in the Optimization of a Self‐Emulsifying Formulation with a High Drug Load , 2004, Pharmaceutical development and technology.

[53]  Miller,et al.  Spontaneous Emulsification of Oils Containing Hydrocarbon, Nonionic Surfactant, and Oleyl Alcohol. , 1999, Journal of colloid and interface science.

[54]  M. Abraham,et al.  The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. , 1999, Journal of pharmaceutical sciences.

[55]  M. Marquezini,et al.  In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[56]  J. Huwyler,et al.  Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. , 2002, International journal of pharmaceutics.

[57]  Dipak K. Sarker.  Engineering of nanoemulsions for drug delivery. , 2005, Current drug delivery.

[58]  A. Tibell,et al.  Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[59]  P. Tso,et al.  An examination of the factors affecting intestinal lymphatic transport of dietary lipids. , 2001, Advanced drug delivery reviews.

[60]  S. Yalkowsky,et al.  A New Parenteral Emulsion for the Administration of Taxol , 1987, Pharmaceutical Research.

[61]  C. Vigo‐Pelfrey,et al.  Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol. , 1993, Chemistry and physics of lipids.

[62]  C. Porter,et al.  The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment. , 2000, International journal of pharmaceutics.

[63]  Ames Mm,et al.  Parenteral formulation of hexamethylmelamine potentially suitable for use in man. , 1982 .

[64]  J. Polli,et al.  Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system. , 1999, International journal of pharmaceutics.

[65]  M. Abdul-Latif,et al.  Comparison of Propofol‐Lipuro with propofol mixed with lidocaine 10 mg on propofol injection pain , 2004, Anaesthesia.

[66]  R. Liu.  Water-insoluble drug formulation , 2000 .

[67]  P. Keipert.  Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion. , 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

[68]  V. Venkateswarlu,et al.  Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion , 2005, Journal of drug targeting.

[69]  M. Rogge,et al.  Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability , 1993, Journal of clinical pharmacology.

[70]  R. Curi,et al.  Effects on Walker 256 tumour of carmustine associated with a cholesterol‐rich microemulsion (LDE) , 2004, The Journal of pharmacy and pharmacology.

[71]  V. Stella,et al.  Preliminary development and evaluation of a parenteral emulsion formulation of penclomedine (NSC-338720; 3,5-dichloro-2,4-dimethoxy-6-trichloromethylpyridine): a novel, practically water insoluble cytotoxic agent. , 1988, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[72]  J. Breitenbach.  Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[73]  D. Crommelin,et al.  Solubilization of lipophilic drugs by amphiphiles: improvement of the apparent solubility of almitrine bismesylate by liposomes, mixed micelles and O/W emulsions , 1987 .

[74]  A. Tsuji,et al.  Entrapping Efficiency of an Oil-in-Water Emulsion Containing Isocarbacyclin Methyl Ester (TEI-9090) in Dog and Human Sera , 1994, Pharmaceutical Research.

[75]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[76]  M. Lawrence.  Microemulsions as drug delivery vehicles , 1996 .

[77]  J. Kovarik,et al.  Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation. , 1994, Transplantation.

[78]  M. Hashida,et al.  Long circulating emulsion carrier systems for highly lipophilic drugs. , 1994, Biological & pharmaceutical bulletin.

[79]  R. Müller,et al.  Solubilizing poorly soluble antimy cotic agents by emulsification via a solvenent-free process , 2004, AAPS PharmSciTech.

[80]  Christos Reppas,et al.  Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data , 1999, Pharmaceutical Research.

[81]  B. Svensson,et al.  Fat emulsion as a vehicle for diazepam. A study of 9492 patients. , 1983, British journal of anaesthesia.

[82]  A. J. Repta,et al.  Solubilization and stabilization of an investigational antineoplastic drug (NSC no. 278214) in an intravenous formulation using an emulsion vehicle , 1983 .

[83]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[84]  A. Driedger,et al.  Review of the toxicologic properties of medium-chain triglycerides. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[85]  Yasuo,et al.  Preparation of Powdered Redispersible Vitamin E Acetate Emulsion by Spray-Drying Technique. , 1991 .

[86]  O. Hernell,et al.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. , 1990, Biochemistry.

[87]  S. E. Walker,et al.  The filling of molten and thixotropic formulations into hard gelatin capsules , 1980, The Journal of pharmacy and pharmacology.

[88]  James E Polli,et al.  Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[89]  L. Rupert,et al.  Physico-Chemical Properties of Selected Anionic, Cationic and Nonionic Surfactants , 1993 .

[90]  T. Takino.  Pharmacokinetic disposition analysis of lipophilic drugs injected with various lipid carriers in the single-pass rat liver perfusion system , 1995 .

[91]  O. Hernell,et al.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. , 1990, Biochemistry.

[92]  F. Pattarino,et al.  LONG-ACTING DELIVERY SYSTEMS FOR PEPTIDES: REDUCED PLASMA TESTOSTERONE LEVELS IN MALE RATS AFTER A SINGLE INJECTION , 1990 .

[93]  N. Charlier,et al.  Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. , 1992, BMJ.

[94]  Y. Rahman,et al.  Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid. , 1990, Journal of pharmaceutical sciences.

[95]  S. Kawakami,et al.  Disposition characteristics of emulsions and incorporated drugs after systemic or local injection. , 2000, Advanced drug delivery reviews.

[96]  A. Seelig,et al.  Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[97]  D. Shah,et al.  Spontaneous Emulsification: Mechanisms, Physicochemical Aspects, Modeling, and Applications , 2002 .

[98]  D. Fernandes,et al.  Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies , 2005, Cancer Chemotherapy and Pharmacology.

[99]  D. Fernandes,et al.  Use of a cholesterol‐rich microemulsion that binds to low‐density lipoprotein receptors as vehicle for etoposide , 2003, The Journal of pharmacy and pharmacology.

[100]  Martin Kuentz,et al.  Determination of the optimal amount of water in liquid-fill masses for hard gelatin capsules by means of texture analysis and experimental design. , 2002, International journal of pharmaceutics.

[101]  Pieter Walstra,et al.  Formation of emulsions. , 1998 .

[102]  A. Burlingham,et al.  PHARMACOKINETICS OF DIAZEPAM EMULSION , 1985, The Lancet.

[103]  B. Lundberg.  The solubilization of lipophilic derivatives of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture , 1994 .

[104]  S. Muranishi,et al.  Studies on pharmaceutical modification of anticancer agents. I. Enhancement of lymphatic transport of mitomycin C by parenteral emulsions. , 1975, Chemical & pharmaceutical bulletin.

[105]  R. Strickley.  Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[106]  Jeong-Sook Park,et al.  Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. , 2004, International journal of pharmaceutics.

[107]  S. Benita,et al.  Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[108]  R. Müller,et al.  SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. , 2004, International journal of pharmaceutics.

[109]  M. Groves,et al.  Hydrolysis Kinetics of Phospholipids in Thermally Stressed Intravenous Lipid Emulsion Formulations , 1992, The Journal of pharmacy and pharmacology.

[110]  V. Stella,et al.  Development of parenteral formulations of experimental cytotoxic agents. I. Rhizoxin (NSC-332598) , 1988 .

[111]  R. Pinney,et al.  Amphotericin B and its delivery by liposomal and lipid formulations , 1993, Journal of clinical pharmacy and therapeutics.

[112]  B. D. Anderson,et al.  Solubilization and Stabilization of an Anti-HIV Thiocarbamate, NSC 629243, for Parenteral Delivery, Using Extemporaneous Emulsions , 1993, Pharmaceutical Research.

[113]  C. Porter,et al.  In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.

[114]  P. Thoren,et al.  Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. , 1998, Journal of pharmaceutical sciences.

[115]  R. A. Forse,et al.  The new dietary fats in health and disease. , 1997, Journal of the American Dietetic Association.

[116]  V. Stella,et al.  The use of oil-in-water emulsions as a vehicle for parenteral drug administration. , 1990, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[117]  N. Garti,et al.  Improved oil solubilization in oil/water food grade microemulsions in the presence of polyols and ethanol. , 2001, Journal of agricultural and food chemistry.

[118]  Joachim Grevel,et al.  Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation , 1994, Pharmaceutical Research.

[119]  V. Stella,et al.  A novel use of Intralipid for the patenterai delivery of perilla ketone (NSC-348407), an investigational cytotoxic drug with a high affinity for plastic , 1988 .

[120]  Robert F. Jimerson,et al.  Soft Gelatin Capsijle Update , 1986 .

[121]  Colin W. Pouton,et al.  Formulation of self-emulsifying drug delivery systems , 1997 .

[122]  Jochem Alsenz,et al.  The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. , 2003, Journal of pharmaceutical sciences.

[123]  K. Wasan.  Formulation and Physiological and Biopharmaceutical Issues in the Development of Oral Lipid-Based Drug Delivery Systems , 2001, Drug development and industrial pharmacy.

[124]  T. Nagai,et al.  Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. , 2003, International journal of pharmaceutics.

[125]  Robert A. Lodder,et al.  Determination of Extent of Formaldehyde-Induced Crosslinking in Hard Gelatin Capsules by Near-Infrared Spectrophotometry , 1997, Pharmaceutical Research.

[126]  L. Kaminsky,et al.  Small intestinal cytochromes P450. , 1991, Critical reviews in toxicology.

[127]  R. Maranhão,et al.  Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. , 2005, Gynecologic oncology.

[128]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[129]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[130]  J. Patton,et al.  The Light Microscopy of Triglyceride Digestion , 1985 .

[131]  M. Lawrence,et al.  A comparison of the incorporation of model steroids into non‐ionic micellar and microemulsion systems , 1993, The Journal of pharmacy and pharmacology.

[132]  P. Bummer,et al.  Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles. , 2004, Critical reviews in therapeutic drug carrier systems.

[133]  M. Goto,et al.  Studies on Dissolution Tests of Soft Gelatin Capsules. V. Rotating Dialysis Cell Method , 1994 .

[134]  M. Läubli,et al.  Determination of the oxidative stability of fats and oils: Comparison between the active oxygen method (AOCS Cd 12-57) and the rancimat method , 1986 .

[135]  M. Maurin,et al.  Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. , 1997, Biopharmaceutics & drug disposition.

[136]  K. Amighi,et al.  Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. , 2003, International journal of pharmaceutics.

[137]  B. Boyd,et al.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.

[138]  W. Charman,et al.  Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. , 2000, Journal of pharmaceutical sciences.

[139]  R. Maskiewicz,et al.  Sterile Filtration of a Parenteral Emulsion , 1992, Pharmaceutical Research.

[140]  Hu Liu,et al.  Preparation and physical characterization of a novel marine oil emulsion as a potential new formulation vehicle for lipid soluble drugs. , 2006, International journal of pharmaceutics.

[141]  G. Edwards,et al.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.

[142]  O. Werner,et al.  Intravenous Infusion of Halothane Dissolved in Fat. Haemodynamic Effects in Dogs , 1984, Acta anaesthesiologica Scandinavica.

[143]  D. Evans,et al.  A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[144]  Lawrence X. Yu,et al.  Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1 , 1999, Pharmaceutical Research.

[145]  S. Davis,et al.  Lipid Emulsions as Drug Delivery Systems , 1987, Annals of the New York Academy of Sciences.

[146]  T. Allen,et al.  Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.

[147]  B. Müller,et al.  The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant , 1998 .

[148]  V. Stella,et al.  Lymphatic Transport of Drugs , 1992 .

[149]  K. Miyajima,et al.  Effects of Cholesterol and Cholesteryl Oleate on Lipolysis and Liver Uptake of Triglyceride/Phosphatidylcholine Emulsions in Rats , 1994, Pharmaceutical Research.

[150]  M. Khan,et al.  Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. , 2002, International journal of pharmaceutics.

[151]  Jean Paul Remon,et al.  Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs , 1998 .

[152]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[153]  A. Serajuddin,et al.  Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility. , 1986, Journal of pharmaceutical sciences.

[154]  J. Wagner,et al.  Anaesthetic properties of pregnanolone emulsion , 1987, Anaesthesia.

[155]  M. Trotta,et al.  Influence of phase transformation on indomethacin release from microemulsions. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[156]  S. S. Davis,et al.  Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers , 1991, The Journal of pharmacy and pharmacology.

[157]  B. Gutsche,et al.  Preliminary Study of a Pregnanolone Emulsion (KABI 2213) for I.V. Induction of General Anaesthesia , 1992, British Journal of Anaesthesia.

[158]  N. Armstrong,et al.  Drug release from lipid-based dosage forms. I , 1980 .

[159]  A. Thomson,et al.  Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. , 1993, Canadian journal of physiology and pharmacology.

[160]  O. Söderman,et al.  Microemulsions based on soybean phosphatidylcholine and triglycerides. Phase behavior and microstructure , 1997 .

[161]  P. Tso,et al.  From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons. , 2001, Advanced drug delivery reviews.

[162]  A. Masclee,et al.  Effects of Medium-Chain and Long-Chain Triglycerides on Antroduodenal Motility and Small Bowel Transit Time in Man , 1997, Digestive Diseases and Sciences.

[163]  N. Porter.  [32] Chemistry of lipid peroxidation , 1984 .

[164]  Jonathan Kenneth Embleton,et al.  Influence of lipolysis on drug absorption from the gastro-intestinal tract , 1997 .

[165]  A. K. Taylor,et al.  Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80 autoxidation. , 1984, Journal of pharmaceutical sciences.

[166]  T. R. Bates,et al.  Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat. , 1973, Journal of pharmaceutical sciences.

[167]  B. Karlén,et al.  Pregnanolone emulsion A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent , 1990, Anaesthesia.

[168]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[169]  William M. Gelbart,et al.  The "New" Science of "Complex Fluids" , 1996 .

[170]  R. Deckelbaum,et al.  In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. , 2005, Clinical nutrition.

[171]  G. Edwards,et al.  Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine , 1998 .

[172]  S. Benita,et al.  The stability and in vitro release kinetics of a clofibride emulsion , 1991 .

[173]  F. Ursini,et al.  Lipid peroxidation in membranes and low-density lipoproteins: similarities and differences. , 2000, Free radical biology & medicine.

[174]  Michael Antolovich,et al.  Methods for testing antioxidant activity. , 2002, The Analyst.

[175]  P. Abuja,et al.  Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[176]  O. Abdallah,et al.  Study of In‐Vitro Release Characteristics of Carbamazepine Extended Release Semisolid Matrix Filled Capsules Based on Gelucires , 2004, Drug development and industrial pharmacy.

[177]  G. Edwards,et al.  Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[178]  Leslie Z. Benet,et al.  Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.

[179]  Clarence A. Miller.  Spontaneous emulsification produced by diffusion. A review , 1988 .

[180]  Y. Masaoka,et al.  Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system. , 2006, Journal of pharmaceutical sciences.

[181]  P. Constantinides,et al.  Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects , 1995, Pharmaceutical Research.

[182]  A. Serajuddin,et al.  Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. , 1988, Journal of pharmaceutical sciences.

[183]  S. Chi,et al.  Stability and solubilization of oxathiin carboxanilide, a novel anti-HIV agent , 1991 .

[184]  W. Ritschel.  Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. , 1996, Clinical transplantation.

[185]  W. Charman,et al.  Lipid-based vehicles for the oral delivery of poorly water soluble drugs , 1997 .

[186]  Davis Ss,et al.  The preparation and properties of sterile intravenous emulsions. , 1983 .

[187]  Y. Mizushima,et al.  Lipid microspheres for drug delivery from the pharmaceutical viewpoint. , 1994, Critical reviews in therapeutic drug carrier systems.

[188]  Y. Pathak,et al.  Enhanced stability of physostigmine salicylate in submicron o/w emulsion , 1990 .

[189]  B. Boyd,et al.  Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. , 2005, Journal of pharmaceutical sciences.

[190]  D. F. Evans,et al.  Spontaneous formation of a water-continuous emulsion from a w/o microemulsion , 1990 .

[191]  N. Dietz,et al.  Phenobarbital Stability in Different Dosage Forms: Alternatives for Elixirs , 1988, Pharmaceutical Research.

[192]  E. Lien,et al.  Structure–activity relationship: analyses of p‐glycoprotein substrates and inhibitors , 2003, Journal of clinical pharmacy and therapeutics.

[193]  Clarence A. Miller,et al.  Spontaneous Emulsification of Oil in Aerosol-OT/Water/Hydrocarbon Systems , 2000 .

[194]  R. Strey.  Microemulsion microstructure and interfacial curvature , 1994 .

[195]  P. Hochbergs,et al.  Clinical Trials with a New Iodinated Lipid Emulsion for Computed Tomography of the Liver , 1989, Acta radiologica.

[196]  K M Park,et al.  Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. , 1999, International journal of pharmaceutics.

[197]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[198]  Feng Liu,et al.  Long-Circulating Emulsions (Oil-in-Water) as Carriers for Lipophilic Drugs , 1995, Pharmaceutical Research.

[199]  J. Kovarik,et al.  The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine. , 1994, Transplantation proceedings.

[200]  B. Derjaguin,et al.  Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solutions of electrolytes , 1993 .